Biovail Acquisition Of Fuisz Adds Microsphere, Rapid Dissolve Drug Delivery
Executive Summary
Biovail's $154 mil. acquisition of Fuisz Technologies will add a drug delivery component to the Canadian pharmaceutical company's branded and generic Rx business.